Identifying Host Cell Death Pathway Targets for Host-Directed Therapies for Treatment of Mtb and Mtb/HIV Co-Infection (R01 Clinical Trial Not Allowed)

Go to Funding Search

Key Information

Due Date: December 7, 2024


Agency: U.S. Department of Health and Human Services (HHS)


Source: Federal


Funding Category:

Health & Human Services

Funding Amount: $581,371


Funding Type: Grant, Philanthropy


Match Required: No


Contact Info: grantsinfo@nih.gov
See Section VII. Agency Contacts within the full opportunity announcement for all other inquires.

Overview

This grant focuses on studying the ways in which cells die and respond to infection by the bacteria Mycobacterium tuberculosis, otherwise known as Mtb, and combined infection of Mtb and HIV. The goal of this grant, titled "Identifying Host Cell Death Pathway Targets for Host-Directed Therapies for Treatment of Mtb and Mtb/HIV Co-Infection", is to encourage research that can provide valuable insight into how the human immune system interacts with these infections. The research supported by this grant can help identify potential immune system targets that can aid in the creation of therapies directly aimed at the host's body, or host-directed therapies. It is important to note that the grant will not fund clinical trials. Ultimately, the aim is to advance our understanding of these diseases and contribute towards more effective treatments.
Show More

Key Dates

Open Date: August 9, 2022


Application Due Date: December 7, 2024


Estimated Award Date: Not Specified

Additional Details

Eligible Activities

  • Research and Development

Eligible Applicants

  • State governments
  • County governments
  • City, village or township governments
  • Special district governments
  • Independent school districts
  • Public and State controlled institutions of higher education
  • Private institutions of higher education
  • Small businesses

Search MI Funding Hub

NOTE: Site search does not include grant search. See Find Funding page for grant searching.